
Vectech provides AI-based pest management solutions globally, empowering health programs and researchers.
Founded in Baltimore, MD, VecTech is a public benefit corporation dedicated to revolutionizing pest management through AI technology. Their core mission is to provide advanced diagnostic tools for medical entomology, enabling effective pest control and disease prevention. VecTech's flagship product, IDX, is an AI-based system that equips municipal and national public health programs, NGOs, malaria control initiatives, and researchers with the expertise of a professional entomologist with minimal training. The company focuses on global health markets, aiming to enhance pest management and reduce disease transmission in seven countries.
VecTech has garnered support from notable contributors and partners in the public health sector. The company's innovative approach has led to significant achievements, including the deployment of IDX in various international health programs. By empowering health workers and researchers with cutting-edge AI tools, VecTech has made a substantial impact on global pest management and disease control efforts. Their commitment to public benefit and technological advancement positions them as a leader in the field of medical entomology.

Bird Brain
raptair.ai

Extrasense Technologies
extrasense.co

Atolla Tech

Mosqitter
mosqitter.com

Insightiv Technologies

Techcyte
techcyte.com

Veseris
Veteran Technology Group
vettechgrp.com
SenesTech
senestech.com

Inzecto
inz-eco.com

Vama Eco
vamainc.com

Zippiai
zippiai.com

AMPLY Discovery
amplydiscovery.com

VectoIQ
vectoiq.com

Vectice
vectice.com
Companies similar to VecTech include Bird Brain, Extrasense Technologies, Atolla Tech and Mosqitter.
VecTech was founded in 2019.
VecTech's headquarters is located in Baltimore, MD, US.
VecTech's most recent funding round was for $20k (USD) in January 2023.
As of Jan 10, 2023, VecTech has disclosed funding of $300.8k (USD). Undisclosed round amounts are excluded.
VecTech has 11 employees as of Feb 4, 2024.